The US Food and Drug Administration promoted Jacqueline Corrigan-Curay to principal deputy center director of the Center for Drug Evaluation and Research effective 4 July, a new position and the first senior leadership change since Patrizia Cavazzoni took over CDER in mid-April.
In Corrigan-Curay’s nearly five years as head of CDER’s Office of Medical Policy, she has worked on a wide range of policy issues that impact the entire drug life cycle, both pre- and post-approval, and represented the agency in a number of public forums – experience that experts say will help Cavazzoni advance her agenda for the drug center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?